Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Chemical Reviews
|
May 17, 2014
Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases
Vladimir N Uversky, Vrushank Davé, Lilia M Iakoucheva, et al.
Molecular Cancer Therapeutics
|
September 19, 2007
Improved low molecular weight Myc-Max inhibitors
Huabo Wang, Dalia I Hammoudeh, Ariele Viacava Follis, et al.
Journal of Medicinal Chemistry
|
February 14, 2009
Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore model
Gabriela Mustata, Ariele Viacava Follis, Dalia I Hammoudeh, et al.
Journal of Biomolecular Screening
|
July 31, 2013
A high-throughput screening assay for fungicidal compounds against Cryptococcus neoformans
Jennifer L A Rabjohns, Yoon-Dong Park, Jean Dehdashti, et al.
Biomaterials
|
March 11, 2006
Promotion of opsonization by antibodies and phagocytosis of Gram-positive bacteria by a bifunctional polyacrylamide
Vijay M Krishnamurthy, Lee J Quinton, Lara A Estroff, et al.
Oncotarget
|
March 3, 2012
Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1
Julie S Barber-Rotenberg, Saravana P Selvanathan, Yali Kong, et al.
Intrinsically Disordered Proteins
|
May 19, 2017
What's in a name? Why these proteins are intrinsically disordered: Why these proteins are intrinsically disordered
A Keith Dunker, M Madan Babu, Elisar Barbar, et al.
Cancer Research
|
January 29, 2021
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers
Adam J Wolpaw, Richard Bayliss, Gabriele Büchel, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Chemical Reviews
|
May 17, 2014
Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases
Vladimir N Uversky, Vrushank Davé, Lilia M Iakoucheva, et al.
Molecular Cancer Therapeutics
|
September 19, 2007
Improved low molecular weight Myc-Max inhibitors
Huabo Wang, Dalia I Hammoudeh, Ariele Viacava Follis, et al.
Journal of Medicinal Chemistry
|
February 14, 2009
Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore model
Gabriela Mustata, Ariele Viacava Follis, Dalia I Hammoudeh, et al.
Journal of Biomolecular Screening
|
July 31, 2013
A high-throughput screening assay for fungicidal compounds against Cryptococcus neoformans
Jennifer L A Rabjohns, Yoon-Dong Park, Jean Dehdashti, et al.
Biomaterials
|
March 11, 2006
Promotion of opsonization by antibodies and phagocytosis of Gram-positive bacteria by a bifunctional polyacrylamide
Vijay M Krishnamurthy, Lee J Quinton, Lara A Estroff, et al.
Oncotarget
|
March 3, 2012
Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1
Julie S Barber-Rotenberg, Saravana P Selvanathan, Yali Kong, et al.
Intrinsically Disordered Proteins
|
May 19, 2017
What's in a name? Why these proteins are intrinsically disordered: Why these proteins are intrinsically disordered
A Keith Dunker, M Madan Babu, Elisar Barbar, et al.
Cancer Research
|
January 29, 2021
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers
Adam J Wolpaw, Richard Bayliss, Gabriele Büchel, et al.
Page
of 2